Find your next paid study

Telios Pharma, Inc.NCT07220408

~$75 – $2,800

Actual pay is set by the research site.

GlioblastomaGlial TumorBrain Metastases+3 more

Clinical Investigation to Evaluate the CONVIVO System for Discrimination of Normal From Abnormal Tissue During Brain Tumor Resection

The primary objective of this study is to evaluate the diagnostic performance of the CONVIVO confocal endomicroscope in discriminating between normal and abnor…

Dartmouth-Hitchcock Medical CenterNCT05139277

Actual pay is set by the research site.

Crohn's DiseaseAbdominal Pain (AP)

A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease

The purpose of this research is to see if patients with Crohn's disease (CD) and abdominal pain resulting in health-related quality of life deficits despite la…

Actual pay is set by the research site.

Mayo ClinicNCT06647615

Dimensional Changes of Autogenous Free Epithelialized Gingival Grafts on Different Bed Preparations Among Dental Patients With Thin Tissue Phenotypes: A Randomized Clinical Trial

The goal of this clinical trial is to evaluate the dimensional changes in the short and long-term in patients with thin gum tissues who have gum grafts placed …

Gingival Recession

University of IowaNCT05684068

Actual pay is set by the research site.

Phase 1

Curcumin and Retinal Amyloid-beta Pilot Study

To test how two weeks of curcumin supplementation would cross the blood brain barrier (BBB) and attach to amyloid beta proteins, to assess the feasibility (saf…

BioavailabilityGut MicrobiomeSafety

Texas Tech University Health Sciences CenterNCT05774704

~$500 – $7,500

Actual pay is set by the research site.

Phase 1

Clinical Evaluation of a Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Triple Negative Breast Cancer (TNBC)

This phase I trial tests the safety, side effects, and best dose of a personalized vaccine (tumor membrane vesicle or TMV vaccine) by itself and in combination…

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+24 more

Post Traumatic Stress DisorderTraumatic Brain Injury

Non-invasive Vagal Nerve Stimulation and Sleep

In this study, our objective is to determine the effect of two different nerve stimulation types in changing sleep architecture.

University of FloridaNCT03170440

Actual pay is set by the research site.

Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)

The FIND-CRC study is a prospective collection of samples and data from participants who are at average risk of developing colorectal cancer (CRC). Collected s…

Colo-rectal Cancer

~$10 – $1,050

Actual pay is set by the research site.

Natera, Inc.NCT07046585

Cardiovascular DiseasesChronic Kidney DiseasesDiabetes Mellitus, Type 2+4 more

Improving the Collaborative Health of Adults With Chronic Conditions & Carepartner Dyads Through Interventions Addressing Social and Health Self-Management Needs.

This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of adults with pre-existing chronic health conditions and th…

University of South CarolinaNCT05370014

Actual pay is set by the research site.

Hernia, VentralPain Management

Quadratus Lumborum Blocks for Pain Control Following Open Ventral Hernia Repair: A Double Blinded Randomized Control Trial

The purpose of this study is to determine whether using a QL block is better than placebo (a look-alike substance that contains no drug) in lowering the amount…

University of Tennessee Graduate School of MedicineNCT06953635

Actual pay is set by the research site.

Phase 1

First-in-human, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study Evaluating the Safety and Immunogenicity of IVT Shigella-04 in Healthy Young Adults

Phase 1 trial to evaluate the Safety and Immunogenicity of Inventprise's (IVT) Shigella-04 in Healthy Young Adults

ShigellaDiarrhea

Inventprise Inc.NCT07205926

~$500 – $10,500

Actual pay is set by the research site.

Phase 3

Open-Label, Multiple-Dose, 52-Week Study + 24-Month Long-Term Safety Extension to Evaluate the Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Deficiency or Absence of Endogenous Testosterone Due to Primary or Secondary Hypogonadism

This is a 52-week open label single arm study + 24-Month long-term safety extension to investigate the effects of XYOSTED, as testosterone replacement therapy,…

Hypogonadism, Male